Dr. Lalchandani Labs Ltd. engages in the provision of diagnostic and related healthcare services. The company is headquartered in New Delhi, Delhi. The company went IPO on 2018-05-09. The firm is engaged in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunology, virology, cytology, and other pathological and radiological investigations. Through its integrated network, the Company offers patients and healthcare providers a range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. The firm provides its own blood banking services through its sister concern CPC blood bank. The firm's customers include individual patients, hospitals and other healthcare providers, and corporate customers.
Loading chart…
This company hasn't held an earnings call in the last six months, so there's no recent commentary from management. Our deep dives are built on what management actually said, so we haven't prepared one.